Liyun Yuan, MD

Title(s)Assistant Professor of Clinical Medicine
SchoolKeck School of Medicine of USC
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Rho Chi Pharmacy Honor Society2004Member
    2005Charles and Charlotte Krown Fellowship
    American Association of Pharmaceutical Sciences2006Graduate Student Award

    Collapse Overview 
    Collapse Overview
    Dr. Yuan is a transplant hepatologist specializing in caring for patients with chronic liver diseases, hepatocellular carcinoma, and pre-/post liver transplantation. She completed her internship and residency training in Internal Medicine at Keck USC School of Medicine, where she further finished gastroenterology fellowship training. After that, she took an extra year advanced training in transplant hepatology at University of Colorado, Denver.

    Dr. Yuan’s clinical research interests include Nonalcoholic fatty liver disease, autoimmune hepatitis and outcome of liver transplantation. She has authored several articles in peer-reviewed journals on various topics in liver disease and liver transplantation. Dr. Yuan's research activities include searching and validating diagnostic markers and prognostic makers in nonalcoholic steatohepatitis, liver targeting of anti-fibrotic therapy, and the role of PGAM5 in hepatic cell death- using the model of acetoaminophen-induced liver injury.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yuan L, Bambha K. Bile acid receptors and nonalcoholic fatty liver disease. World J Hepatol. 2015 Dec 08; 7(28):2811-8. PMID: 26668692.
      View in: PubMed
    2. Yuan L, Kaplowitz N. Mechanisms of drug-induced liver injury. Clin Liver Dis. 2013 Nov; 17(4):507-18, vii. PMID: 24099014; PMCID: PMC3793205.
    3. Han D, Dara L, Win S, Than TA, Yuan L, Abbasi SQ, Liu ZX, Kaplowitz N. Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria. Trends Pharmacol Sci. 2013 Apr; 34(4):243-53. PMID: 23453390; PMCID: PMC3622802.
    4. Yuan L, Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med. 2009 Feb-Apr; 30(1-2):29-41. PMID: 18786561.
      View in: PubMed
    5. Yuan L, Wang J, Shen WC. Reversible lipidization of somatostatin analogues for the liver targeting. Eur J Pharm Biopharm. 2008 Oct; 70(2):615-20. PMID: 18614343.
      View in: PubMed
    6. Yuan L, Wang J, Shen WC. Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugs. J Control Release. 2008 Jul 02; 129(1):11-7. PMID: 18448186.
      View in: PubMed
    7. Yuan L, Wang J, Shen WC. Reversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotide. Pharm Res. 2005 Feb; 22(2):220-7. PMID: 15783069.
      View in: PubMed